Follow
Marco Diana MD PhD
Marco Diana MD PhD
'G. Minardi' Cognitive Neuroscience Lab., Dept of Chemistry and Pharmacy, University of Sassari
Verified email at uniss.it
Title
Cited by
Cited by
Year
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
GL Gessa, M Melis, AL Muntoni, M Diana
European journal of pharmacology 341 (1), 39-44, 1998
3971998
Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence.
M Diana, M Pistis, S Carboni, GL Gessa, ZL RoSSETTI
Proceedings of the National Academy of Sciences 90 (17), 7966-7969, 1993
3931993
The dopamine hypothesis of drug addiction: hypodopaminergic state
M Melis, S Spiga, M Diana
Int Rev Neurobiol 63 (10), 101-54, 2005
3662005
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: a consensus paper on the present state of the science and the road ahead
H Ekhtiari, H Tavakoli, G Addolorato, C Baeken, A Bonci, S Campanella, ...
Neuroscience & Biobehavioral Reviews 104, 118-140, 2019
2652019
The dopamine hypothesis of drug addiction and its potential therapeutic value
M Diana
Frontiers in psychiatry 2, 64, 2011
2612011
Mesolimbic dopaminergic decline after cannabinoid withdrawal
M Diana, M Melis, AL Muntoni, GL Gessa
Proceedings of the National Academy of Sciences 95 (17), 10269-10273, 1998
2571998
Rehabilitating the addicted brain with transcranial magnetic stimulation
M Diana, T Raij, M Melis, A Nummenmaa, L Leggio, A Bonci
Nature Reviews Neuroscience 18 (11), 685-693, 2017
2272017
Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats.
M Diana, M Pistis, A Muntoni, G Gessa
Journal of Pharmacology and Experimental Therapeutics 272 (2), 781-785, 1995
2031995
Acetaldehyde increases dopaminergic neuronal activity in the VTA
M Foddai, G Dosia, S Spiga, M Diana
Neuropsychopharmacology 29 (3), 530-536, 2004
2022004
Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies
R Pirastu, R Fais, M Messina, V Bini, S Spiga, D Falconieri, M Diana
Drug and alcohol dependence 83 (2), 163-168, 2006
1862006
Increase in meso‐prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids
M Diana, M Melis, GL Gessa
European Journal of Neuroscience 10 (9), 2825-2830, 1998
1801998
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal
M Diana, AL Muntoni, M Pistis, M Melis, GL Gessa
European journal of neuroscience 11 (3), 1037-1041, 1999
1611999
Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence
M Diana, M Pistis, A Muntoni, G Gessa
Neuroscience 71 (2), 411-415, 1996
1581996
Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain
M Melis, GL Gessa, M Diana
Progress in Neuro-Psychopharmacology and Biological Psychiatry 24 (6), 993-1006, 2000
1472000
Alcohol withdrawal in rats is associated with a marked fall in extraneuronal dopamine
ZL Rossetti, F Melis, S Carboni, M Diana, GL Gessa
Alcoholism: Clinical and Experimental Research 16 (3), 529-532, 1992
1421992
Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate
L Pulvirenti, M Diana
Reviews in the Neurosciences 12 (2), 141-158, 2001
1332001
Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system
M Melis, P Enrico, AT Peana, M Diana
European Journal of Neuroscience 26 (10), 2824-2833, 2007
1272007
Hampered long-term depression and thin spine loss in the nucleus accumbens of ethanol-dependent rats
S Spiga, G Talani, G Mulas, V Licheri, GR Fois, G Muggironi, N Masala, ...
Proceedings of the National Academy of Sciences 111 (35), E3745-E3754, 2014
1162014
Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation
G Addolorato, L Leggio, FW Hopf, M Diana, A Bonci
Neuropsychopharmacology 37 (1), 163-177, 2012
1152012
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex
GL Gessa, P Devoto, M Diana, G Flore, M Melis, M Pistis
Neuropsychopharmacology 22 (6), 642-649, 2000
1142000
The system can't perform the operation now. Try again later.
Articles 1–20